Viral vaccines have traditionally been live, attenuated viruses, or inactivated virus/subunits. Herpes simplex virus (HSV) vaccine candidates based on inactivated viruses or subunits have not been effective thus far. In addition, attenuation of HSV to make a safe vaccine candidate has not allowed good immunogenicity to be retained. Therefore, novel vaccine strategies have been initiated, including replication-defective and single-cycle HSV strains. In this chapter, I will review the design and properties of these replication-defective virus vaccine candidates and the preclinical and clinical results that have been obtained using them. © Springer Basel AG 2011.
CITATION STYLE
Knipe, D. M., & Knipe, D. M. (2011). Replication-defective herpes simplex virus mutant strains as genital herpes vaccines and vaccine vectors. Birkhauser Advances in Infectious Diseases. https://doi.org/10.1007/978-3-0346-0277-8_12
Mendeley helps you to discover research relevant for your work.